Orum Therapeutics, Inc. (475830.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−35.0x

Market Cap

KRW 1.15T

MomentumView details →

1D Return

−3.20%

YTD Return

−53.42%

RSI (14)

43.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−35.0x

Market Cap

KRW 1.15T

RSI (14)

43.9

MomentumView details →

1D Return

−3.20%

YTD Return

−53.42%

ProfitabilityView details →

Gross Margin

−6803.02%

Net Margin

—

EBITDA Margin

—

ROE (TTM)

25.85%

ROA (TTM)

16.47%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+630.93%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.52x

Current Ratio

3.12x

Quick Ratio

3.12x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

24.12M

Net Income (TTM)

48.09B

Op. CF (TTM)

−52.16B

Latest newsMore news →

No recent news for 475830.KQ.

Similar companies

Kolon TissueGene, Inc.950160.KQ Onconic Therapeutics476060.KQ OliX Pharmaceuticals,Inc226950.KQ Chabiotech Co.,Ltd.085660.KQ Pharmicell Co., Ltd.005690.KS Medy-Tox Inc.086900.KQ Find similar companies →

Latest newsMore news →

No recent news for 475830.KQ.